Characteristics of patients with concomitant hematological malignancy
| MM N (%) | cSCC N (%) | MCC N (%) | P value | |
| Total | 52 (100%) | 15 (100%) | 17 (100%) | |
| Hematological malignancy | 0.30 | |||
| CLL | 16 (30.2%) | 8 (53.3%) | 8 (47.1%) | |
| NHL | 28 (53.8%) | 5 (33.3%) | 5 (29.4%) | |
| other | 8 (15.4%) | 2 (13.3%) | 4 (23.5%) | |
| Age at diagnosis of hematological malignancy | 0.81 | |||
| Median (IQR) | 68.0 years (58.7–76.0) | 66.0 years (59.2–73.0) | 68.0 years (46.7–73.0) |
Characteristics of the total n=84 patient cohort. Percentages are given per column.
Hematological malignancies were categorized as chronic lymphocytic leukemia (CLL), other non-Hodgkin’s lymphoma (NHL), and other (comprising all other entities not belonging to the previous two categories).
cSCC, cutaneous squamous cell carcinoma; MCC, Merkel cell carcinoma; MM, malignant melanoma.